0001062993-23-005847.txt : 20230303 0001062993-23-005847.hdr.sgml : 20230303 20230303160613 ACCESSION NUMBER: 0001062993-23-005847 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flynn Steven CENTRAL INDEX KEY: 0001938766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-04448 FILM NUMBER: 23703838 MAIL ADDRESS: STREET 1: ONE BAXTER PARKWAY CITY: DEERFIELD STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BAXTER INTERNATIONAL INC CENTRAL INDEX KEY: 0000010456 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 360781620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BAXTER PKWY STREET 2: DF2-1W CITY: DEERFIELD STATE: IL ZIP: 60015 BUSINESS PHONE: 8479482000 MAIL ADDRESS: STREET 1: ONE BAXTER PARKWAY STREET 2: DF2-1W CITY: DEERFIELD STATE: IL ZIP: 60015 FORMER COMPANY: FORMER CONFORMED NAME: BAXTER TRAVENOL LABORATORIES INC DATE OF NAME CHANGE: 19880522 FORMER COMPANY: FORMER CONFORMED NAME: BAXTER LABORATORIES INC DATE OF NAME CHANGE: 19760608 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-03-01 0000010456 BAXTER INTERNATIONAL INC BAX 0001938766 Flynn Steven ONE BAXTER PARKWAY DEERFIELD IL 60015 0 1 0 0 SVP, President, APAC Common Stock, $1 par value 2023-03-01 4 A 0 6171 0 A 18737 D Common Stock, $1 par value 2023-03-01 4 A 0 12343 0 A 31080 D Stock Option (Right to Buy) 39.06 2023-03-01 4 A 0 25586 0 A 2033-03-01 Common Stock, $1 par value 25586 25586 D The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. The shares have terms and conditions which provide for vesting at termination if the reporting person is involuntarily terminated prior to the vesting date for other than cause. The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date. /s/ Matthew Rice, as attorney in-fact for Steven Flynn 2023-03-03